NASDAQ:GDRX GoodRx Q3 2026 Earnings Date & Estimates $3.51 0.00 (0.00%) Closing price 11/6/2026 04:00 PM EasternExtended Trading$3.68 +0.17 (+4.73%) As of 06:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. GoodRx is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 9, 2026TimeAfter Market Closes Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from GoodRx in Q3 2026GoodRx is expected to post earnings of $0.0779 per share on revenue of $202.07 million. In the same quarter a year earlier GoodRx reported $0.08 per share on revenue of $196.03 million. GoodRx last reported on August 5, 2026, posting $0.08 per share and beating the $0.0797 consensus estimate. GoodRx has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.0779Expected Revenue$202.07 millionPrior-Year EPS$0.08Prior-Year Revenue$196.03 millionExpected EPS Growth-2.7%Expected Revenue Growth+3.1%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.08 (Beat by +$0.0003)Last Quarter Revenue$200.41 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report GoodRx Q3 2026 Earnings FAQ When does GoodRx report Q3 2026 earnings? GoodRx (NASDAQ:GDRX) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is GoodRx's Q3 2026 earnings call? GoodRx's Q3 2026 earnings conference call is scheduled for Wednesday, November 18, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for GoodRx? Analysts expect GoodRx to post earnings of $0.0779 per share for Q3 2026. How much revenue is GoodRx expected to report? The consensus revenue estimate for GoodRx is $202.07 million for Q3 2026. GoodRx Earnings Headlines3 Penny Stocks With Revenue Growth Up To 44%November 4, 2026 | uk.finance.yahoo.comGoodRx (GDRX) Projected to Release Quarterly Earnings on TuesdayNovember 2, 2026 | americanbankingnews.comOne Ticker Tied to a Coming 401k ChangeAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will delete it without a second look. Larry Benedict says that would be a mistake. He calls this the decade's biggest opportunity and is naming the one ticker to watch before it arrives. Watch his free breakdown now.November 9 at 1:00 AM | Brownstone Research (Ad)GoodRx Holdings Is Going Through A Painful Transition That Will Pay OffOctober 31, 2026 | seekingalpha.comGoodRx Announces Launch Of Employer Direct Weight Loss OfferingOctober 29, 2026 | marketscreener.comMGoodRx Launches Employer Direct Weight Loss OfferingOctober 29, 2026 | finance.yahoo.comSee More GoodRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like GoodRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your email. Email Address About GoodRxGoodRx (NASDAQ:GDRX) operates a digital healthcare platform that helps consumers find and access lower prices for prescription medications. Through its website and mobile applications, GoodRx allows users to compare prices at participating pharmacies, obtain prescription discount coupons and identify potential savings on commonly prescribed drugs. The company’s services are generally available at pharmacies across the United States. GoodRx also offers GoodRx Gold, a membership program that provides additional discounts on eligible prescriptions, as well as healthcare-related content and tools designed to help consumers understand medications and treatment options. Its platform connects consumers with pharmacies, healthcare providers and pharmaceutical companies, supporting prescription savings, medication information and other consumer healthcare services. The company was founded in 2011 by Trevor Bezdek, Doug Hirsch and Scott Marlette. GoodRx became a publicly traded company on the Nasdaq under the symbol GDRX in 2020. Its business is primarily focused on the U.S. healthcare market and is intended to complement, rather than replace, traditional health insurance by helping consumers compare out-of-pocket prescription costs.View GoodRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/2 - 11/6IonQ's Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?The Ugly Truth Behind SoundHound’s Q3 ResultsSandisk Shares Are Oversold: Bargain or Value Trap?Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater? Upcoming Earnings Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026)Honda Motor (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.